| Literature DB >> 20069120 |
C A Bousman1, M Cherner, J H Atkinson, R K Heaton, I Grant, I P Everall, The Hnrc Group.
Abstract
Catechol-O-methyltransferease (COMT) metabolizes prefrontal cortex dopamine (DA), a neurotransmitter involved in executive behavior; the Val158Met genotype has been linked to executive dysfunction, which might increase sexual risk behaviors favoring HIV transmission. Main and interaction effects of COMT genotype and executive functioning on sexual risk behavior were examined. 192 sexually active nonmonogamous men completed a sexual behavior questionnaire, executive functioning tests, and were genotyped using blood-derived DNA. Main effects for executive dysfunction but not COMT on number of sexual partners were observed. A COMT x executive dysfunction interaction was found for number of sexual partners and insertive anal sex, significant for carriers of the Met/Met and to a lesser extent Val/Met genotypes but not Val/Val carriers. In the context of HIV and methamphetamine dependence, dopaminergic overactivity in prefrontal cortex conferred by the Met/Met genotype appears to result in a liability for executive dysfunction and potentially associated risky sexual behavior.Entities:
Year: 2010 PMID: 20069120 PMCID: PMC2804107 DOI: 10.1155/2010/678648
Source DB: PubMed Journal: Interdiscip Perspect Infect Dis ISSN: 1687-708X
Characteristics of full sample by COMT genotype.
| COMT genotype | |||||
|---|---|---|---|---|---|
| Full sample | Val/Val | Val/Met | Met/Met | ||
| ( | ( | ( | ( | ||
| Age (years) | 37 (9) | 35 (9) | 38 (9) | 39 (11) | |
| Education (years) | 13 (2) | 13 (2) | 13 (2) | 14 (2) | |
| WRAT4 | 100 (12) | 99 (11) | 100 (12) | 104 (11) | |
| Caucasian | 71 | 52 | 78 | 83 | v/v < v/m, m/m** |
| African-American | 15 | 32 | 7 | 11 | v/v > v/m, m/m** |
| Hispanic | 14 | 17 | 16 | 6 | |
| Wisconsin card sort test | 45 (14) | 47 (16) | 44 (13) | 46 (13) | |
| Trials part B | 49 (11) | 51 (12) | 47 (10) | 52 (11) | |
| Halstead category Test | 46 (10) | 47 (10) | 44 (10) | 47 (9) | |
| Domain deficit score | .55 (.69) | .56 (.68) | .62 (.74) | .35 (.47) | |
| Executive impairment (%) | 45 | 46 | 50 | 31 | |
| Age at first intercourse | 15 (4) | 14 (4) | 16 (4) | 17 (4) | v/v < m/m* |
| Sexual preference (% heterosexual) | 33 | 35 | 31 | 38 | |
| Number partners in past 12 mo | 3 (1,10) | 4 (1, 11) | 3 (1, 10) | 2 (1, 5) | |
| Condom use (>0% in past 12 mo) | 72 | 74 | 71 | 70 | |
| Insertive anal (>0% in past 12 mo) | 62 | 60 | 67 | 52 | |
| Receptive anal (>0% in past 12 mo) | 58 | 60 | 62 | 46 | |
| Oral sex (>0% in past 12 mo) | 93 | 94 | 93 | 94 | |
| Intoxicated sex (>0% in past 12 mo) | 64 | 63 | 66 | 61 | |
| Vaginal sex (>0% in past 12 mo) | 37 | 35 | 35 | 44 | |
| Major depression | 36 | 36 | 35 | 40 | |
| Bipolar I or II | 4 | 8 | 3 | 3 | |
| Beck depression inventory | 12 (9) | 11 (8) | 13 (10) | 10 (9) | |
| Sedative | 0 | 0 | 0 | 0 | |
| Cannabis | 9 | 9 | 11 | 6 | |
| Opioid | 0 | 0 | 0 | 0 | |
| Cocaine | 7 | 7 | 5 | 14 | |
| Hallucinogen | 0 | 0 | 0 | 0 | |
| Alcohol | 17 | 15 | 20 | 14 | |
| Methamphetamine dependent (%) | 47 | 37 | 52 | 49 | |
| Age at first METH use, yrs | 24 (9) | 23 (9) | 25 (8) | 27 (10) | |
| Total METH use, yrs | 11 (6) | 13 (7) | 11 (6) | 8 (4) | v/v > m/m* |
| Last use of METH, days | 91 (36, 274) | 122 (45, 731) | 91 (32, 236) | 91 (30, 244) | |
| HIV seropositive (%) | 56 | 70 | 51 | 49 | v/v > v/m, m/m* |
| HIV RNA, plasma (log copies/mL) | 2.1 (1.9) | 2.4 (1.7) | 2.0 (2.0) | 1.7 (1.9) | |
Multivariate linear regression coefficients for main, interaction, and stratified effects of executive functioning and COMT in seven sexual risk behavior models.
| Standardized Beta(a) | ||||||
|---|---|---|---|---|---|---|
| Main Effect | Interaction | Straitfied(b) | ||||
| EF measure | EF | COMT | EF × COMT | Val/Val | Val/Met | Met/Met |
| Sexual Risk Behavior Model | ( | ( | ( | ( | ( | ( |
| (1) Partners (# past 12 mo) | 0.21** | 0.10 | 0.50** | 0.03 | 0.20** | 0.52*** |
| (2) Condom use (% past 12 mo) | 0.03 | 0.13 | 0.24 | — | — | — |
| (3) Insertive anal (% past 12 mo) | 0.06 | 0.07 | 0.50** | −0.18 | 0.11 | 0.18 |
| (4) Receptive anal (% past 12 mo) | 0.05 | 0.05 | 0.44* | −0.17 | 0.11 | 0.13 |
| (5) Oral sex (% past 12 mo) | −0.10 | 0.07 | 0.40 | — | — | — |
| (6) Intoxicated sex (% past 12 mo) | 0.07 | −0.06 | 0.08 | — | — | — |
| (7) Vaginal sex (% past 12 mo) | −0.03 | −0.04 | −0.28 | — | — | — |
| (1) Partners (# past 12 mo) | −0.09 | 0.08 | −0.18 | — | — | — |
| (2) Condom use (% past 12 mo) | −0.10 | 0.12 | −0.25 | — | — | — |
| (3) Insertive anal (% past 12 mo) | 0.01 | 0.07 | −0.31 | — | — | — |
| (4) Receptive anal (% past 12 mo) | −0.02 | 0.04 | −0.38 | — | — | — |
| (5) Oral sex (% past 12 mo) | 0.20** | 0.09 | 0.13 | — | — | — |
| (6) Intoxicated sex (% past 12 mo) | −0.04 | −0.07 | 0.32 | — | — | — |
| (7) Vaginal sex (% past 12 mo) | 0.04 | −0.04 | −0.04 | — | — | — |
| (1) Partners (# past 12 mo) | −0.01 | 0.08 | −0.54 | — | — | — |
| (2) Condom use (% past 12 mo) | −0.07 | 0.11 | 0.03 | — | — | — |
| (3) Insertive anal (% past 12 mo) | −0.06 | 0.06 | −0.99** | 0.18 | −0.03 | –0.38** |
| (4) Receptive anal (% past 12 mo) | −0.04 | 0.03 | −0.75* | 0.17 | −0.06 | −0.22 |
| (5) Oral sex (% past 12 mo) | 0.10 | 0.06 | −0.68* | 0.35** | 0.01 | 0.01 |
| (6) Intoxicated sex (% past 12 mo) | −0.11 | −0.07 | 0.13 | — | — | — |
| (7) Vaginal sex (% past 12 mo) | 0.07 | −0.04 | 0.37 | — | — | — |
| (1) Partners (# past 12 mo) | −0.11 | 0.08 | −0.16 | — | — | — |
| (2) Condom use (% past 12 mo) | −0.16** | 0.11 | −1.13** | 0.08 | –0.19* | –0.49*** |
| (3) Insertive anal (% past 12 mo) | 0.01 | 0.05 | −0.22 | — | — | — |
| (4) Receptive anal (% past 12 mo) | −0.01 | 0.03 | −0.59 | — | — | — |
| (5) Oral sex (% past 12 mo) | 0.06 | 0.06 | −0.50 | — | — | — |
| (6) Intoxicated sex (% past 12 mo) | −0.04 | −0.06 | −0.44 | — | — | — |
| (7) Vaginal sex (% past 12 mo) | −0.05 | −0.04 | 0.25 | — | — | — |
(a)all regression models adjusted for METH status, HIV status, age at first intercourse.
(b)stratified analysis of EF effects by genotype was conducted if a significant (P < .10) interaction was observed.
EF: executive functioning; COMT: catechol-O-methyltransferease (0 = Val/Val; 1 = Val/Met; 2 = Met/Met)
*P < .10; **P < .05, ***P < .005.
Figure 1A theoretical model illustrating the interaction effect of a single genotype (i.e., COMT Val158Met polymorphism) and endophenotype (i.e., executive functioning domain deficit) on a behavioral phenotype (i.e., number of sexual partners). Among carriers of the COMT Met/Met and to a lesser extent the Val/Met genotype the association between executive functioning deficit and number of sexual partners is significantly stronger than among carriers of the Val/Val genotype. *P < .05; **P < .01.